Insights from 2023 ESMO Annual Meeting
N

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC - One-Year Follow-Up"

By Insights from 2023 ESMO Annual Meeting FEATURING Neil Gross
By Insights from 2023 ESMO Annual Meeting FEATURING Neil Gross
193 views
November 13, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
09:00

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

759 views
11:53

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

287 views
21:20

Year in Review: Updates in Non-Melanoma Skin Cancers

Dana-Farber Cancer Institute

K. Khaddour

270 views
26:24

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

430 views
13:21

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson

457 views
13:59

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

143 views
58:44

Updates in non-Melanoma Skin Cancer

Head and Neck Symposium: Skin Malignancies Update

S. Daveluy

213 views
15:39

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

141 views
47:34

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

C. Rodriguez

397 views
15:54

Non-Melanoma Skin Cancers

ImmunoTherapy Bridge 2023

P. A. Ascierto

124 views
27:29

2023 ASCO® Direct Philadelphia: Melanoma Updates

Total Health

M. Orloff

133 views
23:44

PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell …

Todd Schlesinger

347 views
24:20

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Scenari…

Insights from 2023 ASCO® Annual Meeting

K. Margolin

186 views
02:41

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in …

ecancer

N. Gross

104 views
12:13

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

AACR 2023 Conference Coverage

E. Cohen

206 views
18:56

Immunotherapy and Anti-Angiogenic Therapies in HNSCC

Yale Cancer Center

A. Bhatia

263 views
26:36

New

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

24 views
09:00

Harnessing IO in the Management of CSCC

Winship Cancer Institute - Emory University

N. Saba

105 views
25:33

Update on HPV Testing in Head and Neck Cancer

Houston Methodist

M. R. Schwartz

198 views
AUTOPLAY